GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NextCell Pharma NXTCL.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.25

-9.95%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 10.9m

FY2016FY2025

Net income

−SEK 35.1m

FY2016FY2025

Free cash flow

−SEK 43.0m

FY2016FY2025

Shareholders' equity

SEK 66.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 10.9mSEK 10.7mSEK 10.1mSEK 5.6mSEK 3.9mSEK 3.6mSEK 1.8mSEK 655,413SEK 517,203SEK 809,006
Operating income−SEK 35.9m−SEK 43.2m−SEK 41.0m−SEK 35.0m−SEK 24.8m−SEK 17.7m−SEK 21.5m−SEK 14.0m−SEK 13.3m−SEK 11.4m
Net income−SEK 35.1m−SEK 42.0m−SEK 39.8m−SEK 34.1m−SEK 24.6m−SEK 17.7m−SEK 21.5m−SEK 14.0m−SEK 13.2m−SEK 11.4m
Diluted earnings per share-0.32-0.57-0.58-0.50-0.36-0.38-0.56-0.66-0.78-2.17

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 76.7mSEK 81.3mSEK 88.8mSEK 124.7mSEK 155.6mSEK 29.8mSEK 26.7mSEK 8.5mSEK 21.6mSEK 9.5m
Cash and short-term investmentsSEK 38.7mSEK 46.8mSEK 50.0mSEK 97.1mSEK 139.2mSEK 22.0mSEK 20.1mSEK 3.1mSEK 16.6mSEK 5.8m
Total liabilitiesSEK 10.3mSEK 13.7mSEK 13.1mSEK 9.1mSEK 5.5mSEK 3.6mSEK 3.8mSEK 3.5mSEK 2.6mSEK 2.7m
Debt————SEK 100,351SEK 63,834SEK 120,400—−SEK 240,000−SEK 480,000
Shareholders' equitySEK 66.4mSEK 67.6mSEK 75.7mSEK 115.5mSEK 150.1mSEK 26.2mSEK 23.0mSEK 5.0mSEK 19.1mSEK 6.8m
Shares outstanding111m73m69m69m69m47m38m21m17m5m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 38.9m−SEK 37.8m−SEK 43.8m−SEK 33.3m−SEK 25.6m−SEK 19.0m−SEK 22.1m−SEK 13.5m−SEK 14.8m−SEK 11.1m
Capital spending−SEK 4.2m−SEK 82,922−SEK 4.1m−SEK 7.6m−SEK 725,930−SEK 787,113−SEK 396,500−SEK 396,500−SEK 396,500−SEK 142,134
Free cash flow−SEK 43.0m−SEK 37.9m−SEK 47.9m−SEK 40.9m−SEK 26.3m−SEK 19.7m−SEK 22.5m−SEK 13.9m−SEK 15.2m−SEK 11.3m

Latest quarters

By quarter end

May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024
RevenueSEK 3.0mSEK 2.7mSEK 1.8mSEK 2.6mSEK 2.3mSEK 3.2mSEK 2.8mSEK 1.6m
Operating income−SEK 11.7m−SEK 10.6m−SEK 14.0m−SEK 8.8m−SEK 10.4m−SEK 8.6m−SEK 8.3m−SEK 13.6m
Net income−SEK 11.7m−SEK 10.4m−SEK 13.8m−SEK 8.6m−SEK 10.3m−SEK 8.2m−SEK 8.0m−SEK 13.2m
Diluted earnings per share-0.09-0.08-0.12-0.08-0.09-0.07-0.11-0.18
Cash from operations−SEK 11.0m−SEK 7.0m−SEK 22.0m−SEK 10.0m−SEK 8.0m−SEK 6.0m−SEK 12.0m−SEK 7.0m
Capital spending——−SEK 2.0m−SEK 1.0m—−SEK 1.0m——
Free cash flow——−SEK 24.0m−SEK 11.0m—−SEK 7.0m——
Total assetsSEK 63.9mSEK 69.8mSEK 63.9mSEK 76.7mSEK 52.2mSEK 61.5mSEK 69.3mSEK 81.3m
Cash and short-term investmentsSEK 21.1mSEK 32.3mSEK 26.0mSEK 38.7mSEK 16.7mSEK 26.3mSEK 34.1mSEK 46.8m
Shareholders' equitySEK 47.1mSEK 55.0mSEK 50.6mSEK 66.4mSEK 41.1mSEK 51.4mSEK 59.6mSEK 67.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue25.1%25.1%108.8%
Operating income0.8%15.2%13.2%
Net income1.0%14.7%13.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-365.9%-415.7%-441.2%-552.1%
Net margin-356.9%-404.8%-431.6%-542.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-1.0-0.9-0.4-1.4-2.1-4.5-1.0-0.8-0.6
Price to sales3.23.41.78.313.022.212.218.115.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.